Alvotech (ALVO) Invested Capital (2020 - 2026)
Alvotech's (ALVO) quarterly Invested Capital came in at $1.2 billion in Q2 2026, up 14.42% on a YoY basis from $1.0 billion in Q2 2025, and up 9.93% quarter-over-quarter from $1.0 billion in Q1 2026.
Analysis
Alvotech (ALVO) Invested Capital (2020 - 2026) Analysis & Trends
Alvotech (ALVO) has reported Invested Capital for 7 consecutive years, with $1.2 billion the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Invested Capital rose 14.42% year-over-year to $1.2 billion; the trailing twelve-month figure through Jun 2026 stood at $1.2 billion (up 14.42% YoY), and the FY2025 full-year result was $1.1 billion, up 23.39% from the prior year.
- Invested Capital rose to $1.2 billion in Q2 2026 per ALVO's latest filing, from $1.0 billion in the prior quarter.
- Across five years, Invested Capital topped out at $1.2 billion in Q2 2026 and bottomed at $307.6 million in Q2 2023.
- Historically, Invested Capital has averaged $787.6 million across 5 years, with a median of $866.4 million in 2024.
- The sharpest annual moves came in 2022 and 2023: Invested Capital surged 118.67% in 2022, then plunged 33.16% in 2023.
- Over 5 years, Invested Capital stood at $580.4 million in 2022, then slipped by 5.54% to $548.2 million in 2023, then surged by 57.97% to $866.0 million in 2024, then advanced by 23.39% to $1.1 billion in 2025, then grew by 7.92% to $1.2 billion in 2026.
- According to Business Quant data, Invested Capital over the past three periods registered $1.2 billion, $1.0 billion, and $1.1 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.63 Bn | 38.97 Bn | 2.15 Bn | 24.35 Bn |
| 2 | Viatris | 19.19 Bn | 18.30 Bn | 1.46 Bn | 27.61 Bn |
| 3 | Dr Reddys Laboratories | 9.86 Bn | 9.69 Bn | 396.53 Mn | 4.90 Bn |
| 4 | Amneal Pharmaceuticals | 5.48 Bn | 5.35 Bn | 334.51 Mn | 2.70 Bn |
| 5 | Bausch Health Companies | 2.36 Bn | 520.30 Mn | 2.10 Bn | 19.84 Bn |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | 1.15 Bn |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | 898.70 Mn |
| 8 | Amphastar Pharmaceuticals | 995.52 Mn | 705.40 Mn | 93.47 Mn | 1.38 Bn |
| 9 | Fennec Pharmaceuticals | 404.35 Mn | 363.10 Mn | 17.15 Mn | - |
| 10 | RedHill Biopharma | 176.59 Mn | 176.59 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.15 Bn |
| Mar 31, 2026 | 1.05 Bn |
| Dec 31, 2025 | 1.07 Bn |
| Sep 30, 2025 | 921.80 Mn |
| Jun 30, 2025 | 1.01 Bn |
| Mar 31, 2025 | 894.18 Mn |
| Dec 31, 2024 | 866.04 Mn |
| Sep 30, 2024 | 866.81 Mn |
| Jun 30, 2024 | 651.66 Mn |
| Mar 31, 2024 | 650.29 Mn |
| Dec 31, 2023 | 548.22 Mn |
| Jun 30, 2023 | 307.64 Mn |
| Dec 31, 2022 | 580.39 Mn |
| Jun 30, 2022 | 460.27 Mn |
| Dec 31, 2021 | 265.42 Mn |
| Dec 31, 2020 | 235.35 Mn |